Question #148570. Asked by pehinhota.
Last updated Jul 19 2021.
Originally posted Jul 18 2021 1:31 PM.
Abdala, technical name CIGB-66, is a COVID-19 vaccine developed by the Center for Genetic Engineering and Biotechnology in Cuba. This vaccine candidate, named after a patriotic drama by Cuban independence hero José Martí, is a protein subunit vaccine containing COVID-derived proteins that trigger an immune response. The full results of the clinical trial have not yet been published. This candidate followed a previous one called CIGB-669 (MAMBISA).https://en.m.wikipedia.org/wiki/Abdala_(vaccine)